Which action is explicitly described as a sponsor responsibility related to stability and retention of the investigational product?

Which action is explicitly described as a sponsor responsibility related to stability and retention of the investigational product?

• A. Take steps to ensure the IP is stable over the period of use.
• B. Maintain unlimited quantities of IP
• C. Terminate retention of samples
• D. Ignore regulatory requirements

Answer: (A)

Under ICH GCP, the sponsor has the responsibility to ensure the investigational product remains stable for the duration it is used in the trial. This means putting in place and following a proper stability program, providing appropriate storage conditions, handling procedures, and documentation so the IP retains its quality, potency, and safety profile throughout the study. By proactively managing stability, the sponsor helps protect participant safety and maintains the integrity of the trial data, since degraded or compromised product could alter outcomes or introduce risks. This is why taking steps to ensure the IP is stable over the period of use is the best description of sponsor responsibility. It encompasses appropriate storage, monitoring, and adherence to shelf-life and handling instructions. Other options don’t fit because unlimited quantities aren’t a mandated or practical obligation, retention of samples is typically required to be maintained for a defined period (not terminated), and ignoring regulatory requirements is never appropriate.

Under ICH GCP, the sponsor has the responsibility to ensure the investigational product remains stable for the duration it is used in the trial. This means putting in place and following a proper stability program, providing appropriate storage conditions, handling procedures, and documentation so the IP retains its quality, potency, and safety profile throughout the study. By proactively managing stability, the sponsor helps protect participant safety and maintains the integrity of the trial data, since degraded or compromised product could alter outcomes or introduce risks.

This is why taking steps to ensure the IP is stable over the period of use is the best description of sponsor responsibility. It encompasses appropriate storage, monitoring, and adherence to shelf-life and handling instructions. Other options don’t fit because unlimited quantities aren’t a mandated or practical obligation, retention of samples is typically required to be maintained for a defined period (not terminated), and ignoring regulatory requirements is never appropriate.